Published in Medical Letter on the CDC and FDA, July 24th, 2005
"Molecular library screening will give academic researchers the ability to combine high throughput approaches with unique biology to rapidly find small molecule modulators of targets and processes," said Dr. Dave Weaver, director of the Molecular Recognition and Screening Facility at the Vanderbilt Institute of Chemical Biology and a research assistant professor of pharmacology.
"Only in the past few years has high-throughput screening become...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.